Our new publication @JCI_insight. Tremendous collaboration with Robb Flynn @VUMCresearch and @Novartis. Integration of RNAseq, chromatin signaling and CRISPR screen reveals ZNF469 is a transcriptional regulator of #fibrosis in human #MASLD, #NAFLD https://t.co/XViTnp45g6
Congratulations to @DrMonaMash on publishing her latest manuscript from our @American_Heart funded study!
@JLGamboa_Velez
@VUMCResearch
@vumcdiabetes
https://t.co/JyWS2mW8R7
Amazing CV Research Day celebration @VUMC_heart with @alan_daugherty giving keynote address. Congrats @AzuahTheShort in @AmandaDoranLab for best student abstract. Record turnout to promote cardiovascular science @VUMCResearch.
Outstanding CV grand rounds @VUMC_heart today from @AartiAsnaniMD on cardiac toxicities from chemotherapy and potential new therapeutic pathways. Beautiful and careful science. #VUMC#CardioOnc#HeartFailure
On clinical service now. This @statnews article really resonates. Easy to forget priorities in all the data and EHR. Be present with patients.https://t.co/EkPHhmpykP
Fantastic seminar from Tony Rosenzweig @VUMCResearch @VUMC_heart at our weekly research seminar in CV medicine on impact of exercise in cardiac plasticity. Next time in person for sure!
Important study by Dan Clark et al @VUMC_heart on #COVID19 myocarditis in athletes. Not all LGE = myocarditis. Power of comparators in research! COVID-19 Myocardial Pathology Evaluation in AthleTEs with Cardiac Magnetic Resonance (COMPETE CMR) https://t.co/qnsxZZFuo8
A big congrats to Mac Linton, Kasey Vickers and team at @VUMChealth @VUMC_heart on this PPG investigating HDL function in human disease! @KaseyVickers @JonBrownLabVUMC @AmandaDoranLab@JonathanBrownMD https://t.co/oYMjAjMNdU
Interesting read in @WSJ about role of managers in business. But, ideas clearly relevant to organizing a research lab. Managers (change to PI) as "coaches" and not authority figures. https://t.co/IxmbKJvCEL
Read this study from Paul Cohen @RockefellerUniv about Brown Fat in humans and risk of cardiometabolic disease. Nice to see independent work from former @BrighamFellows. https://t.co/ATScpg7Zqx
These associations are raising the really exciting notion that perhaps the presence of brown fat protects against these obesity-associated diseases. โPaul Cohen, the Rockefeller University / @RockefellerUniv https://t.co/qiD6PbvzKo
In vivo base editing shows promise in treating the genetic accelerated-aging disorder HutchinsonโGilford progeria syndrome in mice - find out more in our latest highlight of research by @jonbrownlabVUMC
@davidrliu@LiuGroup et al. https://t.co/hvQBfHResT
@VerveTx announces one-time treatment with DNA base editor lowers cholesterol in sustained manner over 6 months in non-human primates. A bold therapeutic concept for #heartdisease in #HeFH. https://t.co/uKL4Cse1dz
In a new Broad video, @NIHDirector, Jonathan Brown (@VUMChealth), and @davidrliu describe the impact of their recent work on treating #progeria in an animal model -- a story that began thirty-six years ago. Watch: https://t.co/vqXgJWvY0Q
#PfizerVaccine dose #2. Feels like we are closing in on an end to #Covid_19. TGIV! Great way to end the week on a positive note. Proud to be part of @VUMChealth @VUMC_heart rollout. We can beat this!
So proud of this work demonstrating DNA base editing treatment for #progeria in human cells & mouse model. Amazing collaborative team @davidrliu @NIHDirector @LukeKoblan & Mike Erdos at NIH and my @VUMCResearch team @lindsaymdavison & Sean Doherty
https://t.co/6MN8Nq4gxt